Latest News about Pablo Zuanic
Recent news which mentions Pablo Zuanic
Clever Leaves 2Q: Neutraceuticals Up, Preparing For Cannabis Flower Exports From Colombia
August 12, 2022
From Benzinga
Projected Benefits For TerrAscend Overestimated, Says Cantor & Downgrades Cannabis Stock To 'Neutral'
August 12, 2022
Tickers
TRSSF
From Benzinga
From Benzinga
From Benzinga
What Makes A Bullish Sign For This Publicly Traded Cannabis Tech Company? Cantor Explains
August 08, 2022
From Benzinga
This Analyst Cut Price Target On Canopy Growth After Q1 Earnings Release, Here's Why
August 05, 2022
From Benzinga
Sen. Cory Booker Says He's Optimistic About Federal Marijuana Decriminalization After Signaling Possible Compromise
August 04, 2022
From Benzinga
Analysts Going Hard On Tilray, Slashing Price Targets; How Much Adj. EBITDA Really Improved?
August 02, 2022
From Benzinga
Volatility Of Cannabis Stocks: Schumer's Bill Was A 'Hail Mary', But Industry Has Other Catalysts – Experts Explain
August 01, 2022
From Benzinga
From Benzinga
Cannabis In New Jersey: How Did The Market Change Since Recreational Weed Was Legalized?
July 29, 2022
From Benzinga
Cantor Fitzgerald Downgrades Ratings On 2 Canadian Cannabis Stocks To Neutral, Here's Why
July 25, 2022
From Benzinga
High Tide Faces 'Tough Market Climate' For Retail, Analyst Lowers Price Target On Cannabis Stock
July 25, 2022
From Benzinga
From Benzinga
This Analyst Is Bullish For Cannabis Stocks: Can Schumer's Bill Get 60 Votes In 'Holy Grail' Scenario?
July 21, 2022
Tickers
BILL
From Benzinga
This Analyst Expects Stabilization Across Canadian Cannabis Market, Revises Sales Estimates For Cannabis LPs
July 21, 2022
From Benzinga
These Are The Top Cannabis Stock Picks According To 3 Of The Top Equity Analysts In The Marijuana Market
July 19, 2022
From Benzinga
OrganiGram Beat Fact Set Expectations: "The Stock Represents Good Value," Analyst Says
July 14, 2022
Tickers
OGI
From Benzinga
2Q Canada Recreational Cannabis Market Analysis: +21 YoY Growth Outperforming The U.S.
July 14, 2022
From Benzinga
Medical Marijuana Sales In US Plunge As Recreational Biz Bounces Back, Analyst Opines On Ways To Build Market Resilience
July 13, 2022
From Benzinga
Why Higher Prices Aren't Always A Bad Thing: This Analyst Explains The Canadian Cannabis Flower Market
July 08, 2022
From Benzinga
Will Constellation Brands Buy Canopy Growth? This Analyst Discusses Optionality Post Debt Transactions
July 06, 2022
Tickers
CGC
From Benzinga
Cantor's Top Picks: Could Q2 Earnings Provide A Spark For These Cannabis Multi-State Operators?
July 05, 2022
From Benzinga
Canopy Growth - Cointreau Trademark Battle Ends, Fitch Ratings Downgrades Canopy Stock
June 28, 2022
From Benzinga
From Benzinga
From Benzinga
Is A Compromise On The Horizon? Why Schumer Might Act On Cannabis Banking Sooner Rather Than Later
June 10, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.